Sort
51,593 grants matching “hepatitis”
Longitudinal integration of environmental exposures, omics, and childhood NAFLD (LEON) Study
$784,467Vaia Lida Chatzi · University Of Southern California · U01 · FY2025 · HG
Beyond BMI: Role of Body Composition, Coronary Microvascular Dysfunction and HFpEF in Characterizing Cardiometabolic Disease Phenotypes
$784,362Viviany R Taqueti · Brigham And Women'S Hospital · R01 · FY2025 · HL
Nutrition, terminal NAD metabolites and cardiovascular disease
$784,329Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · HL
Nutrition, terminal NAD metabolites and cardiovascular disease
$784,329Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · HL
Spectinomycin analogs for NTM infections
$784,246Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2023 · AI
Infection-homing nanosystems as antibacterial therapeutics-delivery platforms
$784,101Michael J Sailor · University Of California, San Diego · R01 · FY2021 · AI
Chemical Stabilization of shRNAs and their development as hepatitis C drugs
$783,579Brian H. Johnston · Somagenics, Inc. · R44 · FY2013 · AI
Modeling immune impairments and pathogenesis in novel humanized mice for HBV-HIV co-infection
$783,487Lishan Su · Univ Of North Carolina Chapel Hill · R01 · FY2019 · AI
Extracellular vesicle cargo and risk of NAFLD and NASH in Latino youth
$783,329Johanna K Distefano · Translational Genomics Research Inst · R01 · FY2023 · DK
Modeling immune impairments and pathogenesis in novel humanized mice for HBV-HIV co-infection
$783,177Lishan Su · University Of Maryland Baltimore · R01 · FY2022 · AI
Modeling immune impairments and pathogenesis in novel humanized mice for HBV-HIV co-infection
$783,177Lishan Su · University Of Maryland Baltimore · R01 · FY2021 · AI
A Rhesus Macaque Model of HIV and HBV co-infection
$782,991Benjamin J Burwitz · Oregon Health & Science University · R01 · FY2024 · AI
Novel IL-23 inhibitor for the treatment of alcohol associated liver disease
$782,852Rohit Loomba · University Of California, San Diego · U01 · FY2020 · AA
HIV AND HEPATITIS IN YOUNG INJECTORS: A COMMUNITY STUDY
$782,773University Of California San Francisco · R01 · FY2001 · DA
2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
$782,512Maria Mori Brooks · University Of Pittsburgh At Pittsburgh · U24 · FY2022 · HL
Bupropion for smoking cessation during pregnancy
$782,511Gary D Hankins · University Of Texas Med Br Galveston · R01 · FY2015 · DA
NIH Director's Pioneer Award
$782,500Karla Kirkegaard · Stanford University · DP1 · FY2006 · OD
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
$782,391Raymond Luke Comenzo · Tufts Medical Center · R01 · FY2025 · CA
Core J: Virology and Molecular Biomarkers Core
$782,351Guido Silvestri · Emory University · P30 · FY2020 · AI
The Impact of Mitochondrial Repression and Lipid Accumulation by HIF on Tumor Growth
$782,337Amato J. Giaccia · Stanford University · R35 · FY2015 · CA
SPECS: Safe Pediatric Euglycemia in Cardiac Surgery
$782,159Michael Agus · Boston Children'S Hospital · R01 · FY2011 · HL
Discovery of Antivirals Targeting Mpox Virus
$782,142Stefan G Sarafianos · Emory University · R01 · FY2024 · AI
Fourier transform-ion cyclotron-resonance mass spec
$782,028Institute For Systems Biology · S10 · FY2003 · RR
Development and validation of a novel 3D human in vitro model of nonalcoholic steatohepatitis to be used for novel therapeutic screening and research on disease mechanism.
$782,018Alice Chen · Organovo, Inc. · R44 · FY2018 · DK
Community-based, client-centered prevention homes to address the rural opioid epidemic
$781,715Ryan Patrick Westergaard · University Of Wisconsin-Madison · UH3 · FY2019 · DA